Bank of America Corp. and two executives are facing a proposed class action alleging they misled investors about the scope of the bank's anti-money laundering ...
Copyright © 2026 The respective authors. Distributed by JD Supra, LLC. All rights reserved. The national conversation about so-called junk fees — charges hidden until the final stage of a consumer ...
Samsung Electronics America Inc. is facing a proposed class action in California federal court alleging its Smart TVs unlawfully intercept and monetize users' ...
The Michigan Supreme Court narrows Michigan Consumer Protection Act exemption for residential builders and revives a conduct-specific standard under the Michigan Consumer Protecti ...
Chinese investors who fell victim to a high-profile Ponzi scheme have been attempting to recover over £3.8 billion of Bitcoin currently held by the Metropolitan Police. The inves ...
On 14 October 2026, the government published a consultation on reforming the employment status framework, as well as additional protections for the genuinely ...
On September 29, 2026, the final phase of the Section 232 pharmaceutical tariffs established by Presidential Proclamation 11020 (the Proclamation), became effective, subjecting ma ...
The U.S. Food and Drug Administration (FDA) issued new draft guidance on premarket submissions for robotically assisted surgical devices (RASDs). We see the guidance as a notable ...
Recent state enforcement actions and legislation involving artificial intelligence (AI) chatbots are testing how existing medical licensing, consumer protection and healthcare regulatory requirements ...
Effective January 1, 2027, California will require certain federal Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") filers with a California nexus to submit a complete ...
Washington expanded its material health care transaction notice law in 2026. Engrossed Substitute House Bill 2548, enacted as Chapter 222 of the 2026 Washington Laws, took effect ...
On October 14, 2026, the Food and Drug Administration (FDA) announced the launch of a Rare Disease Framework Initiative to advance a regulatory framework "purpose-built" for the d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results